GRAVES’ DISEASE STUDY

If you or a loved one is living with Graves’ disease, a clinical study may be able to help. Click the button below to learn more about the study.

Who’s Included?
Adults; All genders
18–65
Drug & Formulation
BHV-1300
Injection
Possibility of Placebo
What is Graves’ Disease?
Graves’ disease is an autoimmune disorder that affects the thyroid gland, a small gland located in your neck. It occurs when the immune system mistakenly attacks the thyroid, causing it to become overreactive and produce too many thyroid hormones – a condition called hyperthyroidism.
Graves’ disease can cause problems throughout the entire body. Common symptoms include:
- Anxiety
- A fast or irregular heartbeat
- Tremors
- Difficulty sleeping
- Fatigue
- Excessive sweating
- Rapid bowel movements
- Weight loss
- Changes in the menstrual cycle.
- Some people can develop an enlarged thyroid and serious eye problems, often referred to as Thyroid Eye Disease (TED).
Although Graves’ disease primarily affects the thyroid, it can cause complications in other parts of the body if left untreated.
- You must be 18-65 years old.
- Participants must have confirmed Graves’ disease.
- Participant has a history of hyperthyroidism not caused by Graves’ disease.
- History of treatment with radioactive iodine or thyroid surgery.
Learn more about the benefits of joining our trial and see if you qualify today!
Frequently Asked Questions
Graves’ disease is often diagnosed by a primary care physician, though you may be referred to an endocrinologist. Diagnosis typically involves reviewing your symptoms and medical history and running tests—such as blood work to check thyroid hormone or antibody levels—and sometimes imaging scans or an ultrasound.
Graves’ disease can affect the body in many ways. In people with Graves’ disease, the immune system mistakenly attacks the thyroid, causing it to produce an excess of thyroid hormone. The antibodies and excess of thyroid hormone can lead to an acceleration of the body’s functions, causing a number of issues related to the eyes, skin, heart, muscles and bones as well as weight, sleep and mood. In women, Graves’ disease may cause issues with menstrual and reproductive health.
There is no cure for Graves’ disease, but it is treatable. Biohaven is studying a novel small-molecule therapy to treat the root cause of Graves’ disease. Learn more about Graves’ disease and potential symptom management options by consulting with a healthcare professional.
About 15 people will participate in this study.
The study is being conducted on behalf of Biohaven .
No. If you qualify and are chosen to participate, you will receive all study-related care, sometimes including an investigational study drug, at no cost to you.
Your participation is fully voluntary. You may leave the study at any time.
By joining a clinical trial, you not only gain access to potential new treatments but also help advance science. Every participant’s experience adds valuable knowledge that can lead to better care and hope for people living with chronic conditions, such as Graves’ disease. Learn more about the benefits of joining a clinical trial.
Visit the See If You Qualify page if you are interested in participating in this study.
Need help talking about Graves’ disease?
Whether it’s with a loved one or your doctor, talking about Graves’ disease can be difficult. Click below to download Biohaven’s Graves’ disease patient conversation guide.
PDF | 5 MB

